By Peter Orengo
A next generation anti-malarial drug that can fight resistance may soon hit the markets after researchers announced positive results on a drug still under clinical trials.
Bold Reporting Takes Time, Courage and Investment. Stand With Us.
- Unlimited access to all premium content
- Uninterrupted ad-free browsing experience
- Mobile-optimized reading experience
- Weekly Newsletters
- MPesa, Airtel Money and Cards accepted